PO-0732: Toxicity and outcome in moderately hypofractionated radiotherapy for 590 prostate cancer patients

MLA

Stefania Volpe, et al. “PO-0732: Toxicity and Outcome in Moderately Hypofractionated Radiotherapy for 590 Prostate Cancer Patients.” Radiotherapy and Oncology, vol. 123, May 2017, pp. S384–85. EBSCOhost, https://doi.org/10.1016/s0167-8140(17)31169-6.

APA

Stefania Volpe, Cristiana Fodor, A. Maucieri, A. Viola, Andrea Vavassori, Alessia Surgo, Giulia Marvaso, Gennaro Musi, Patrick Maisonneuve, Delia Ciardo, Barbara Alicja Jereczek-Fossa, O. De Cobelli, & Roberto Orecchia. (2017). PO-0732: Toxicity and outcome in moderately hypofractionated radiotherapy for 590 prostate cancer patients. Radiotherapy and Oncology, 123, S384–S385. https://doi.org/10.1016/s0167-8140(17)31169-6

Chicago

Stefania Volpe, Cristiana Fodor, A. Maucieri, A. Viola, Andrea Vavassori, Alessia Surgo, Giulia Marvaso, et al. 2017. “PO-0732: Toxicity and Outcome in Moderately Hypofractionated Radiotherapy for 590 Prostate Cancer Patients.” Radiotherapy and Oncology 123 (May): S384–85. doi:10.1016/s0167-8140(17)31169-6.